Polpharma SA

Polpharma has announced a collaboration with Indian player MSN Laboratories that will see the Polish firm distribute MSN’s hospital portfolio in its home market. Billing itself as “the leader of th

Poland’s biopharma sector is best known for its strengths in generics and biosimilars, with companies like Polpharma SA providing central Europe and beyond with a reliable flow of affordable off-pat

Medicines for Europe’s 30th annual conference in Dublin earlier this month saw a packed house for its concluding panel, which brought together six leading executives from top European off-patent indus

Formycon continues to secure launches in global markets for its ranibizumab biosimilar FYB201 as the German firm introduces the Lucentis rival in Canada and Switzerland, where it will be marketed as